Chitin is the second most abundant polymer in nature, found as a structural component in fungi 1 , arthropods 2 , and parasitic nematodes 3, 4 . Mammals do not synthesize chitin, but they express two known enzymes that digest chitin: acidic mammalian chitinase (AMCase) 5 and chitotriosidase 6 . It is known that AMCase is expressed in the lung and the gastrointestinal tract of humans and mice, and that its activity is markedly increased in epithelial cells and macrophages in response to the type 2 cytokines IL-4 and IL-13, yet its role in type 2 inflammation and immunity remains unclear [7] [8] [9] . Most studies investigating AMCase function have focused on its role in allergic lung disease. Mice congenitally lacking AMCase (AMCase-deficient) demonstrated little to no role for the enzyme in acute models of housedust-mite-or ovalbumin (OVA)-induced allergy in the lung 10 . These findings contrasted with those of another published study in which neutralizing AMCase activity with allosamidin or with a monoclonal antibody resulted in marked diminution of IL-13-driven allergic inflammation, suggesting that the enzyme might represent an attractive therapeutic target in allergic asthma 7 . Still, additional reports have proposed that AMCase has a protective role. One showed that the type 2 inflammatory response following chitin challenge was ameliorated in mice overexpressing AMCase 8 , and another observed increased allergic lung disease in mice specifically lacking AMCase enzymatic activity 11 . The contrasting functional implications of AMCase highlighted in these studies have yet to be fully reconciled. Further, allergic inflammation recapitulates the prototypic type 2 response seen after helminth infection 12 , but, surprisingly, despite the discovery that AMCase is highly expressed after exposure to helminths 13 , it has remained unknown whether the enzyme has any role in the host immune response to these important human pathogens.
In this study, we used AMCase-deficient mice as a means to dissect the role of the enzyme in several models of helminth infection and type 2 cytokine-driven airway inflammation. We show that although AMCase activity is largely dispensable in the development of allergic airway disease, the enzyme plays a critical role in the development of type 2 immunity to the gastrointestinal nematodes N. brasiliensis and H. p. bakeri.
RESULTS

Fewer ILCs but normal allergy in AMCase-deficient mice
Our initial studies were focused on reconciling the conflicting observations generated in models of allergic lung inflammation. We postulated that the higher doses of allergen used in a previously published study (involving intranasal sensitization and challenges with 100 µg house dust mite allergen, HDM) could have masked a role for AMCase, thus accounting for the different observations described above 10, 11 . Accordingly, we administered a low-dose allergen time course (intranasal sensitization and challenges with 25 µg and 5 µg HDM, respectively) to AMCase-deficient mice. A day after the last of four challenge doses, we found that the low doses of allergen increased the lung tissue expression of Chia1, the gene encoding AMCase in wild-type mice (Fig. 1a) , but that both wild-type and AMCase-deficient mice exhibited similar pulmonary inflammatory pathology (Fig. 1b) . In the tissue, AMCase abrogation did not have a significant impact on leukocyte or eosinophil accumulation or on gene expression of the type 2 cytokines IL-5 and IL-13 ( Fig. 1c) . At this time point, genes for type 2 initiators IL-33 and TSLP and for the alternative activation markers Relmα and Mrc1 also were expressed at similar levels in both groups of mice. Moreover, AMCase deficiency did not alter type 2 inflammation in the airways (Fig. 1d) . Confirming that these observations were not unique to HDM, we found similar results with papain, a nonchitinous allergen (Supplementary Fig. 1 ). We were able to detect gene expression of chitotriosidase in naive and allergic lung tissue, although it was not elevated during the allergic response (Fig. 1e) . Inquiries into whether chitotriosidase has a critical function in lung allergy and into the differences between mice with enzymatically inactive AMCase and mice deficient in the entire AMCase protein remain to be performed.
Although AMCase ablation had no effect on the development of allergic disease, we found evidence that the innate type 2 response was reduced in AMCase-deficient mice. Following only sensitization with HDM, fewer total leukocytes and fewer IL-5 + IL-13 + type 2 innate lymphoid cells (ILC2 cells) were observed in the lungs of AMCase-deficient mice (Fig. 1f) . In addition, fewer ILCs expressed GATA-3 protein, a transcription factor critically required for the development of ILC2s 14 . Although AMCase-deficient mice ultimately overcame this defect at later time points, these data suggest, for the first time, an important role for AMCase in type 2 immune priming upstream of ILCs. Whether this early immune priming defect explains why polymorphisms of AMCase are associated with airway allergy requires further investigation 15 . Our data indicate that AMCase plays a role in the initiation of type 2 immune responses but is not required for the establishment of type 2 allergic inflammation in the lung.
We also extended our studies to a chronic model of HDM-induced allergy over 6 weeks, and here, too, found little to no role for AMCase (Fig. 2) . These data bolster the conclusions of previous studies showing that AMCase ablation does not have a significant effect A r t i c l e s on allergic airway pathology. They also support other reports that chitotriosidase is the primary active chitinase in the lung 16, 17 .
Lung granulomas form without AMCase
Next, we investigated whether AMCase is required for the type 2 response to helminth parasites known to increase AMCase expression 13, 18 . We began by using a Schistosoma mansoni parasite egg-induced pulmonary granuloma model, in which intravenously injected eggs that become trapped in the pulmonary vasculature trigger endothelial cell damage, potent type 2 inflammation, and IL-4-plus IL-13-dependent granuloma formation. S. mansoni egg exposure led to an IL-13-dependent upregulation of Chia1, which was more robust than that induced by HDM (Fig. 3a) .
Immunofluorescence staining localized the protein expression predominantly to bronchial epithelial cells (Fig. 3b) . Despite the marked induction of AMCase in wild-type lungs, granuloma formation ( Fig. 3c) , fibrosis ( Fig. 3d) , mucus production ( Fig. 3e) , granulomatous eosinophil accumulation (Fig. 3f) , and total leukocyte accumulation in bronchoalveolar lavage fluid (BALF) (Fig. 3g) were unimpaired in AMCase-deficient mice, demonstrating AMCase is not categorically required to mount wild-type antiparasite responses. Likewise, intratracheal delivery of schistosome egg antigen (SEA) upregulated Chia1 in the lung, but the type 2 response was unaffected in AMCase-deficient mice, suggesting that the lack of phenotypic alteration was not due to the route of antigen delivery (intravascular versus epithelial exposure, Supplementary Fig. 2 ). Instead, the findings support the lung allergy studies that concluded AMCase does not have important regulatory activity in the lung.
AMCase is critical for protection against N. brasiliensis AMCase is highly expressed in the gastrointestinal tract (GI), but it was unknown whether AMCase is important for the development of immunity to gastrointestinal parasites that elicit a type 2-polarized protective immune response. GI roundworms or nematodes, which, unlike the flatworm trematode S. mansoni, are known to contain chitin in their mouthparts, larval sheaths, and eggshells 3, 4 , infect over 2 billion people, contributing to substantial morbidity and mortality worldwide 19 . We sought to understand the role of AMCase in host protection using the rodent nematode N. brasiliensis, which has been used extensively to study and model the immunobiology of human hookworm infestation 20 . In the mouse model, after subcutaneous injection of infectious larvae, N. brasiliensis traverses the lung within 1-2 d before migrating up the trachea and entering the GI tract, where larvae mature into egg-laying adults. Wild-type mice successfully expel the worms by around 10-14 d after initial infection 21 . We enumerated the number of N. brasiliensis larvae in the wild-type or AMCase-deficient guts 5, 8, 10, and 14 d after infection. The number of worms that traversed the lungs and took residence in the gut on day 5 did not differ between AMCase-sufficient and -deficient mice (Fig. 4a) . Although wild-type mice expelled the worms nearly completely by day 10, as expected, AMCase-deficient mice harbored significantly more worms in the intestine, and most did not fully clear the infection even by day 14 (Fig. 4a) . The impaired host response resulting from AMCase deficiency was also characterized by a marked increase in the number of parasite eggs in the feces of infected AMCase-deficient mice (Fig. 4b) .
To investigate the reasons for the impairment in host defense, we harvested lung, stomach, and intestinal tissue 8 d after infection, the peak of expulsion in wild-type mice. In the lung, Chia1 expression was upregulated as previously described 8 , but Il13 and the majority of known effector molecules tested were expressed comparably in wild-type and AMCase-deficient mice (Supplementary Fig. 3 ). Only Chil3 (the gene encoding the chitinase-like protein, Ym1) expression was significantly impaired (P < 0.05) in AMCase-deficient lungs even a few days after worm passage-which is notable because Ym1 induces IL-17 and neutrophilic inflammation in the lung that has been postulated to compromise the fitness of N. brasiliensis larvae 22 . Reminiscent of the original description of AMCase 5 , Chia1 expression in the intestines was undetectable, but it was higher, by at least one order of magnitude, in the stomach than in the lung (Fig. 4c) . In contrast to the lung, where expression held steady, intestines of AMCase-deficient mice had greatly diminished expression of chitotriosidase during N. brasiliensis infection (Fig. 4d) . The gene-expression profile in the intestine also correlated with a broadly impaired host response to N. brasiliensis, with AMCase-deficient mice exhibiting markedly reduced expression of Il13 and several key downstream type 2 effector genes (Fig. 4d) . Il13 expression was reduced by npg more than 50%, and Chil3 expression, which is upregulated over 2,000-fold in infected wild-type intestine, was nearly completely abrogated, approaching the levels found in uninfected mice. Perhaps most notably, AMCase was necessary for normal expression of Retnlb, the gene encoding another mediator previously shown to be essential for normal nematode expulsion 21 . Expression of Clca1, which encodes a chloride channel (Gob5) involved in mucus production 23 , was also reduced. This defect likely explains the diminished production of mucus from intestinal goblet cells, which is also critical to the development of protective immunity 24 (Fig. 4e) . Accordingly, the kinetics of N. brasiliensis clearance in the AMCase-deficient mice were similar to those seen in past studies of mice deficient in IL-13 signaling 25, 26 . Collectively, our data show that AMCase is necessary for mice to mount normal type 2 immunity against N. brasiliensis.
Impaired immunity against H. p. bakeri
Lastly, because AMCase is expressed in the lung, we sought to explore whether the defective type 2 response in AMCase-deficient mice after N. brasiliensis infection was also observed after primary and secondary infection with H. p. bakeri, a rodent nematode that is acquired orally, is restricted to the GI tract, and does not migrate through the lungs. Also, in contrast to the N. brasiliensis model, wild-type mice do not clear primary infection with H. p. bakeri, but upon antihelminthic treatment, subsequent infections are successfully eliminatedmaking this an ideal model in which to explore the role of AMCase in the development and maintenance of secondary immunity. Wildtype mice showed a marked increase in Chia1 mRNA expression in the stomach after infection that was absent in AMCase-deficient mice (Fig. 5a) . Moreover, as expected, there was no difference in worms recovered from the tissue between the two groups of mice after a primary infection, but impairment of the host immune-mediated worm expulsion in AMCase-deficient mice was strikingly apparent after a secondary infection (Fig. 5b) . Wild-type mice had nearly cleared all adult H. p. bakeri worms 15 d after reinfection, but AMCase-deficient mice still harbored an average of ~50 worms. Even though the worm burden was not affected by AMCase deficiency during primary infection, the fecundity of the worms differed significantly: H. p. bakeri egg output in the AMCase-deficient mice was more than threefold greater than in wild-type animals (Fig. 5c) . We observed higher ATP uptake in the worms recovered from AMCase-deficient mice, correlating with the increased fecundity and suggestive of increased worm vitality (Fig. 5d) . As with N. brasiliensis infection, AMCase-deficient intestines expressed much less Il13 after both primary and secondary H. p. bakeri infections (Fig. 5e) . This again corresponded with significantly reduced Chil3 and Retnlb expression in both infections. Clca1 expression was significantly lower in AMCase-deficient mice, and this was mirrored by the presence of less luminal and cellular mucus in the intestines (Fig. 5f) . We ruled out that the immune defect is T cell intrinsic by transferring CD4 + T cells from H. p. bakeri-infected wild-type and AMCase-deficient Fig. 4 ).
Since we found evidence of defective immune priming in AMCasedeficient lungs (Fig. 1f) , we hypothesized that immune priming was also deficient in response to GI nematodes. In the duodenum, the type 2 alarmin Il33 was expressed at similar levels in wild-type and AMCase-deficient mice in the hours after H. p. bakeri worms first reached the proximal intestine (Supplementary Fig. 5 ). Among the leukocytes in the mesenteric lymph node at this time, however, we found that the percentage and total number of CD103 + MHCII + CD11b + dendritic cells were significantly diminished (Fig. 5g) . CD103 + DCs have been reported to have a unique capacity to induce gut-homing activity in responding T cells in the mesenteric lymph node 27 . These data show that AMCase has a critical role in initiating type 2 immunity against H. p. bakeri in the host GI tract. npg DISCUSSION Collectively, our data indicate that AMCase regulates the early priming of type 2 immune responses in the lung and the GI tract, but that its role in generating protective antinematode immunity in the GI tract is much more critical than its role in the lung. AMCasedeficient and wild-type mice develop similar acute and chronic type 2-driven allergic lung pathology in response to HDM, SEA, or papain inhalation. AMCase ablation also had no effect on the development of type 2-driven granuloma formation around helminth eggs in the lung. In contrast, AMCase is essential for optimal IL-13 production during infection with N. brasiliensis and H. p. bakeri infection, which is required to activate downstream antiparasite effector molecules (such as Ym1 and Relmβ) and mucus production that cooperatively facilitate parasite expulsion from the intestine.
It is possible that dominance of chitotriosidase in the lung might explain the different outcomes in the lung and gut; chitotriosidase gene expression was largely unaffected by AMCase ablation during allergen challenge but was greatly diminished in intestines of AMCase-deficient mice during N. brasiliensis infection. Also, because the stomach exhibits both constitutive and IL-13-inducible AMCase activity, this might serve as the critical location for the initiation of antinematode type 2 immunity as N. brasiliensis and H. p. bakeri both pass through the stomach on their way to the intestine. Indeed, a prominent role for AMCase in the stomach and duodenum is expected because its chitinolytic activity is greatest at low pH. AMCase functions as a true chitinase in the stomach, as previously suggested 28 ; therefore, it is quickly transported into the duodenum, where it may aid in the disruption, release, and/or processing of parasite-associated chitinous antigens that are critical for the initiation of protective type 2 responses in the gut. We found no evidence that the defective type 2 responses observed during nematode infection were T cell intrinsic. Instead, it is likely that the absence of AMCase results in less processing of parasite chitin in the stomach, which would reduce the release of chitin fragments and other antigens that serve as adjuvants for type 2 immunity 8 . This is certainly consistent with the decrease in type 2 immunity and increase in parasite load, fecundity, and worm vitality observed in the infected AMCase-deficient mice. Finding fewer CD103 + DCs in the intestine-draining mesenteric lymph nodes of AMCase-deficient mice also indicates that AMCase stimulates the antiparasite immune response. There is no existing literature suggesting a required role for CD103 + DCs in type 2 responses to parasites 29 , but there is evidence they are the major migratory dendritic cell population that presents soluble luminal antigen to T cells 30 .
AMCase has long been associated with type 2 cytokine responses that mediate pathogenic allergic inflammation and beneficial immunity to gastrointestinal parasites. The role of AMCase in these widespread diseases, however, has remained unclear. We show here that AMCase has a critical and nonredundant role in type 2 immune priming during infection with the chitin-containing nematode parasites N. brasiliensis and H. p. bakeri. Because AMCase showed a less significant regulatory role in models of allergic lung inflammation and humans lack the machinery to synthesize chitin, it is likely that global exposure to geohelminths rather than airborne allergens provided critical evolutionary pressure to preserve AMCase activity in the human genome.
METhODS
Methods and any associated references are available in the online version of the paper. 
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This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank MedImmune for generating the anti-AMCase rabbit sera, C. Mainhart for genotyping, T. Gieseck and K. Kindrachuk for discussions, and the animal care staffs of Buildings 50 and 14BS at the US National Institutes of Health's Bethesda, Maryland campus for the conscientious care of mice. by washing with 0.5% saponin (Sigma) and stained with antibodies for CD4 (1:500 dilution; RM4-5; BDBiosciences), IL5 (1:200 dilution), IL13 (1:100 dilution), and CD16/32 (1:500 dilution) in the same buffer for 45 min at 4 °C. The cells were again washed in 0.5% saponin before being resuspended in FACS buffer for analysis with a BD LSRFortessa flow cytometer. Type 2 innate lymphoid cells were identified as live Lin − TCRβ − CD4 − Thy1.2 + CD45 + IL-5 + IL-13 + . Some cells were left unstimulated for measurement of Gata3 expression. These cells were processed as above until they were permeabilized with Fixation/Permeabilization solution (eBioscience) and then stained with antibodies against CD4 (1:400 dilution; RM4-5; BioLegend) and Gata3 (1:40 dilution; L50-823; BDBiosciences) and washed with permeabilization buffer (eBioscience). Gata3 + innate lymphoid cells were also identified with a BD LSRFortessa. All antibodies are commercially available, and validation profiles and references are available on corresponding commercial websites.
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Leukocyte isolation from mesenteric lymph nodes for dendritic cell identification. RNA isolation and quantitative real-time PCR. Lung, stomach, or intestinal tissue was homogenized in TRIzol Reagent (Life Technologies) using Precellys 24 (Bertin Technologies). Total RNA was extracted from the homogenate by addition of chloroform followed by the recommendations of the MagMax-96 Total RNA Isolation Kit (Life Technologies). RNA was then reverse transcribed using SuperScript II Reverse Transcriptase (Life Technologies). Real-time RT-PCR was performed on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Quantities of mRNA expressed by a particular gene were determined using Power SYBR Green PCR Master Mix (Applied Biosystems), normalized to ribosomal protein, large, P2 (RPLP2) mRNA levels in each sample, and then articulated as a relative increase or decrease compared with
